Clinical Trials Browser

Phase 2 × OTHER × Hepatitis C × Clear all

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT00513461 2018-08-10

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Phase 2 Completed

110 enrolled 21 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT03261349 2017-08-25

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Phase 2 Unknown

Hepatitis C, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone